Plain-English translation of NCT07087873 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a treatment called transcranial alternating current stimulation (tACS)—a non-invasive procedure that uses gentle electrical currents applied to the scalp to potentially improve memory and thinking problems. The study is designed for people with inflammatory demyelinating diseases (conditions where the immune system damages nerve protective coating in the brain and spinal cord), including multiple sclerosis and neuromyelitis optica spectrum disease. Researchers want to understand how this treatment works in the brain and whether it can help reduce cognitive symptoms.
People with inflammatory demyelinating diseases often struggle with memory, concentration, and other thinking problems that affect their daily lives. Current treatments don't fully address these cognitive symptoms, so researchers are exploring whether non-invasive brain stimulation could offer a new way to help improve brain function and quality of life.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive either real brain stimulation or a placebo (sham) stimulation through electrodes placed on your scalp. Throughout the study, you would complete tests to measure your memory and thinking abilities, and researchers may perform brain imaging or electrical measurements to understand how the treatment affects your brain. The study involves regular visits to the hospital, and you'll need to be reliable about attending appointments and following the study schedule.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China